Citation

BibTex format

@article{Asai:2020:10.1080/21505594.2020.1781486,
author = {Asai, M and Li, Y and Spiropoulos, J and Cooley, W and Everest, D and Robertson, BD and Langford, PR and Newton, SM},
doi = {10.1080/21505594.2020.1781486},
journal = {Virulence},
pages = {811--824},
title = {A novel biosafety level 2 compliant tuberculosis infection model using a ΔleuDΔpanCD double auxotroph of Mycobacterium tuberculosis H37Rv and Galleria mellonella},
url = {http://dx.doi.org/10.1080/21505594.2020.1781486},
volume = {11},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Mammalian infection models have contributed significantly to our understanding of the host-mycobacterial interaction, revealing potential mechanisms and targets for novel antimycobacterial therapeutics. However, the use of conventional mammalian models such as mice, are typically expensive, high maintenance, require specialised animal housing, and are ethically regulated. Furthermore, research using Mycobacterium tuberculosis (MTB), is inherently difficult as work needs to be carried out at biosafety level 3 (BSL3). The insect larvae of Galleria mellonella (greater wax moth), have become increasingly popular as an infection model, and we previously demonstrated its potential as a mycobacterial infection model using Mycobacterium bovis BCG. Here we present a novel BSL2 complaint MTB infection model using G. mellonella in combination with a bioluminescent ΔleuDΔpanCD double auxotrophic mutant of MTB H37Rv (SAMTB lux) which offers safety and practical advantages over working with wild type MTB. Our results show a SAMTB lux dose dependent survival of G. mellonella larvae and demonstrate proliferation and persistence of SAMTB lux bioluminescence over a 1 week infection time course. Histopathological analysis of G. mellonella, highlight the formation of early granuloma-like structures which matured over time. We additionally demonstrate the drug efficacy of first (isoniazid, rifampicin, and ethambutol) and second line (moxifloxacin) antimycobacterial drugs. Our findings demonstrate the broad potential of this insect model to study MTB infection under BSL2 conditions. We anticipate that the successful adaptation and implementation of this model will remove the inherent limitations of MTB research at BSL3 and increase tuberculosis research output.
AU  - Asai,M
AU  - Li,Y
AU  - Spiropoulos,J
AU  - Cooley,W
AU  - Everest,D
AU  - Robertson,BD
AU  - Langford,PR
AU  - Newton,SM
DO  - 10.1080/21505594.2020.1781486
EP  - 824
PY  - 2020///
SN  - 2150-5594
SP  - 811
TI  - A novel biosafety level 2 compliant tuberculosis infection model using a ΔleuDΔpanCD double auxotroph of Mycobacterium tuberculosis H37Rv and Galleria mellonella
T2  - Virulence
UR  - http://dx.doi.org/10.1080/21505594.2020.1781486
UR  - https://www.ncbi.nlm.nih.gov/pubmed/32530737
UR  - https://www.tandfonline.com/doi/full/10.1080/21505594.2020.1781486
UR  - http://hdl.handle.net/10044/1/79974
VL  - 11
ER  -
Download

Considering a Fellowship in Bacteriology?

Want to become an independent PI?
Fellowships at CBRB

Where we are

CBRB
Imperial College London
Flowers Building
Exhibition Road
London SW7 2AZ